Cell MedX Corp. announced that it has appointed Mr. Dwayne Yaretz, Mr. George Adams and Mr. Joao (John) da Costa as members of the Company's Audit Committee. The Company also announces that Mr. Joao da Costa has resigned as Chief Operating Officer of the Company.

Mr. da Costa will continue to serve as a director of Cell MedX and as a member of the audit committee. Following Mr. da Costa's resignation as Chief Operating Officer, Mr. da Costa and Mr. Adams are "independent" within the meaning set forth in National Instrument 52-110 Audit Committees ("NI 52-110").